Global Anti-Viral Drug Therapy Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends
2 Mar, 2021
The anti-viral drug therapy market consists of sales of branded and generic anti-viral drugs and related services by entities (organizations, sole traders and partnerships) that manufacture branded or generic anti-viral drugs to treat microbial infections. The anti-viral drug therapy industry includes establishments that manufacture anti-viral drugs, which are used to treat diseases or illnesses caused by viral infections. Examples of antiviral drugs include idoxuridine, famiciclovir, cidofovir, amantadine, zanamivir, tenofovir, adefovir and ribavirin.
Global Anti-Viral Drug Therapy Market Size And Drivers:
The global anti-viral drug therapy market is expected to grow from $46.45 billion in 2019 to $ 61.57 billion in 2020 at a rate of 32.5%. The market is then expected to grow at a CAGR of 8.3% from 2021 and reach $74.38 billion in 2023. The market is expected to reach $ 87.23 billion in 2025, and $130.12 billion in 2030. The anti-viral drug therapy market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies.
Request For A Sample For The Global Anti-Viral Drug Therapy Market Report:
Trends In The Global Anti-Viral Drug Therapy Market
Companies in the antiviral drug therapy market are increasingly focusing on development and launch of combination drug therapy for treating HIV and other viral infections. Combination therapy involves the formulation of different drugs for treating different diseases. Combination therapy for treating viral infections has been proved effective in suppressing the replication of viruses and reducing antiviral resistance.
Global Anti-Viral Drug Therapy Market Segments:
The global anti-viral drug therapy market is further segmented based on drug class, application and geography.
By Drug Class:DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others.
By Application:HIV, Hepatitis, Herpes, Influenza, Others.
By Geography:The global anti-viral drug therapy market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Among these regions, North America is the largest region in the global anti viral drug therapy market, accounting to 50.6% of total market.
Read More On The Report For The Global Anti-Viral Drug Therapy Market At:https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market
Anti-Viral Drug Therapy Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides anti-viral drug therapy market overviews, analyzes and forecasts market size and growth for the global anti-viral drug therapy market, anti-viral drug therapy market share, anti-viral drug therapy market players, anti-viral drug therapy market segments and geographies, anti-viral drug therapy market’s leading competitors’ revenues, profiles and market shares. The anti-viral drug therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.